There's a joke here, but I'm too busy (re)lining up text in InDesign to make it at the moment....
Pfizer Awaits FDA Approval for Exubera
Pfizer's shares rose in early trading in the wake of a premature announcement from the company that the FDA approved its drug Exubera, an inhaled human insulin powder.
Tags: drugs